Lamin A and lamin C, both products of Lmna, are key components of the nuclear lamina. In the mouse, a deficiency in both lamin A and lamin C leads to slow growth, muscle weakness, and death by 6 weeks of age. Fibroblasts deficient in lamins A and C contain misshapen and structurally weakened nuclei, and emerin is mislocalized away from the nuclear envelope. The physiologic rationale for the existence of the 2 different Lmna products lamin A and lamin C is unclear, although several reports have suggested that lamin A may have particularly important functions, for example in the targeting of emerin and lamin C to the nuclear envelope. Here we report the development of lamin C–only mice (Lmna+/+), which produce lamin C but no lamin A or prelamin A (the precursor to lamin A). Lmna+/+ mice were entirely healthy, and Lmna+/+ cells displayed normal emerin targeting and exhibited only very minimal alterations in nuclear shape and nuclear deformability. Thus, at least in the mouse, prelamin A and lamin A appear to be dispensable. Nevertheless, an accumulation of farnesyl–prelamin A (as occurs with a deficiency in the prelamin A processing enzyme Zmpste24) caused dramatically misshapen nuclei and progeria-like disease phenotypes. The apparent dispensability of prelamin A suggested that lamin A–related progeroid syndromes might be treated with impunity by reducing prelamin A synthesis. Remarkably, the presence of a single LmnaLCO allele eliminated the nuclear shape abnormalities and progeria-like disease phenotypes in Zmpste24–/– mice. Moreover, treating Zmpste24–/– cells with a prelamin A–specific antisense oligonucleotide reduced prelamin A levels and significantly reduced the frequency of misshapen nuclei. These studies suggest a new therapeutic strategy for treating progeria and other lamin A diseases.
Loren G. Fong, Jennifer K. Ng, Jan Lammerding, Timothy A. Vickers, Margarita Meta, Nathan Coté, Bryant Gavino, Xin Qiao, Sandy Y. Chang, Stephanie R. Young, Shao H. Yang, Colin L. Stewart, Richard T. Lee, C. Frank Bennett, Martin O. Bergo, Stephen G. Young
Title and authors | Publication | Year |
---|---|---|
Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna−/− Mice
RL Frock, SC Chen, DF Da, E Frett, C Lau, C Brown, DN Pak, Y Wang, A Muchir, HJ Worman, LF Santana, WC Ladiges, PS Rabinovitch, BK Kennedy |
PloS one | 2012 |
Nuclear Lamins in the Brain — New Insights into Function and Regulation
HJ Jung, JM Lee, SH Yang, SG Young, LG Fong |
Molecular Neurobiology | 2012 |
The nuclear lamins: flexibility in function
B Burke, CL Stewart |
Nature Reviews Molecular Cell Biology | 2012 |
Lamin B1 loss is a senescence-associated biomarker
A Freund, RM Laberge, M Demaria, J Campisi, TM Magin |
Molecular biology of the cell | 2012 |
Neonatal progeria: increased ratio of progerin to lamin A leads to progeria of the newborn
J Reunert, R Wentzell, M Walter, S Jakubiczka, M Zenker, T Brune, S Rust, T Marquardt |
European Journal of Human Genetics | 2012 |
Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA
HJ Jung, C Coffinier, Y Choe, AP Beigneux, BS Davies, SH Yang, RH 2nd, J Hong, T Sun, SJ Pleasure, SG Young, LG Fong |
Proceedings of the National Academy of Sciences | 2012 |
Alternative nuclear transport for cellular protein quality control
A Rose, C Schlieker |
Trends in Cell Biology | 2012 |
Understanding the roles of nuclear A- and B-type lamins in brain development
SG Young, HJ Jung, C Coffinier, LG Fong |
The Journal of biological chemistry | 2012 |
Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice
J Liao, YT Chung, AL Yang, M Zhang, H Li, W Zhang, L Yan, GY Yang |
Molecular Carcinogenesis | 2012 |
Type-I Prenyl Protease Function Is Required in the Male Germline of Drosophila melanogaster
K Adolphsen, A Amell, N Havko, S Kevorkian, K Mears, H Neher, D Schwarz, SR Schulze |
G3: Genes|Genomes|Genetics | 2012 |